Metraipolis › archive › dc_e240e14e0eae

Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42362555
DOI
10.1038/s41523-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-31T08:34:46.478Z
SHA-256 of the archived text
38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef
Stable URL of this page
https://metraipolis.com/documento/dc_e240e14e0eae

How to cite

Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555 — Europe PMC (en), https://europepmc.org/article/MED/42362555 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e240e14e0eae (Metraipolis archive dc_e240e14e0eae, sha256 38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef)
BibTeX
@misc{dce240e14e0eae,
  title = {Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42362555},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e240e14e0eae; sha256 38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42362555. Agents can read the archived copy with the MCP tool read_document.